Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 9, 1997, Pages 1592-1598

  Gardell, Luis R ^a   Reid, Larry D ^a   Boedeker, Kirsten L ^a   Liakos, Thomas M ^a   Hubbell, Christopher L ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Alcoholism; Ethanol; Isradipine; Naltrexone; Pharmacotherapy

Indexed keywords

ISRADIPINE; NALTREXONE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FLUID INTAKE; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALIA;

EID: 0031445952     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04494.x     Document Type: Article

References (29)

1. O'Brien CP, Volpicelli LA, Volpicelli JR: Naltrexone in the treatment of alcoholism: A clinical review. Alcohol 13:35-39, 1996
2. Reid LD: Endogenous opioids and alcohol dependence: Opioid alkaloids and the propensity to drink alcoholic beverages. Alcohol 13:5-11, 1996
3. Volpicelli JR, O'Brien CP, Alterman AI, Hayashida M: Naltrexone and the treatment of alcohol dependence: Initial observations, in Reid LD (ed): Opioids, Bulimia, and Alcohol Abuse & Alcoholism. New York, Springer-Verlag, 1990, pp 195-214
4. Schilling RF, Sachs C: Attrition from an evening alcohol rehabilitation program. Am J Drug Alcohol Abuse 19:239-248, 1993
5. Fratta W, Kuzmin A, Martellotta MC, Cessa GL: The calcium antagonist isradipine inhibits cocaine and morphine reinforcing properties in rats. Soc Neurosci Abstr 17:887, 1991
6. Gonzales PM, Boswell KJ, Hubbell CL, Reid LD: Isradipine, an 1-type calcium channel blocker, and cocaine's ability to facilitate pressing for intracranial stimulation. Pharmacol Biochem Beh'av (in press), 1997
7. Kuzmin A, Zvartau E, Cessa GL, Martellotta MC, Fratta W: Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 41:497-500, 1992
8. Martellotta MC, Kuzmin A, Muglia P, Cessa GL, Fratta W: Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats. Psychopharmacology 113:378-380, 1994
9. Pani L, Kuzmin A, Martellotta MC, Cessa GL, Fratta W: The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res Bull 26:445-447, 1991
10. Fadda F, Garau B, Colombo G, Cessa CL: Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanolpreferring rats. Alcohol Clin Exp Res 16:449-452, 1992
11. Rezvani AH, Pucilowski O, Janowsky DS: Effects of different Ca++ channel antagonists on alcohol preference in alcohol preferring rats. Alcohol Clin Exp Res 15:314, 1991
12. Gardell LR, Hubbell CL, Reid LD: Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage. Alcohol Clin Exp Res 20:584-588, 1996
13. Reid LD, Gardell LR, Chattopadhyay S, Hubbell CL: Periodic naltrexone and propensity to take alcoholic beverage. Alcohol Clin Exp Res 20:1329-1334, 1996
14. Samson H, Files F, Brice G: Patterns of ethanol consumption in a continuous access situation: The effect of adding a sweetener to the ethanol solution. Alcohol Clin Exp Res 20:101-109, 1996
15. Hubbell CL, Reid LD: Opioids modulate rats' intake of alcoholic beverages, in Reid LD (ed): Opioids, Bulimia, and Alcohol Abuse & Alcoholism. New York, Springer-Verlag, 1990, pp 145-174
16. Reid LD, Hubbell CL: Opioids modulate rats' propensities to take alcoholic beverages, in Naranjo CA, Sellers EM (eds): Novel Pharmacological Interventions for Alcoholism. New York, Springer-Verlag, 1992, pp 121-134
17. Hubbell CL, Czirr SA, Reid LD: Persistence and specificity of small doses of morphine on intake of alcoholic beverages. Alcohol 4:149-156, 1987
18. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD: Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone across repeated daily administrations. Alcohol 3:39-54, 1986
19. Reid LD, Pabello NG, Cramer CM, Hubbell CL: Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Life Sei 60:PL119-PL126, 1997 .
20. McKinzie DL, Eha R, McBride WJ, Murphy JM, Lemung L, Li T-K: Evidence for neuroadaptive changes that occur during abstinence and promote alcohol relapse. Alcohol Clin Exp Res 2(Suppl.):15A, 1996
21. Meisch RA: Ethanol self-administration: Infrahuman studies. Adv Behav Pharmacol 1:35-84, 1977
22. Sinclair JD, Bender DD: Compensatory behaviors: Suggestion for a common basis from deficits in hamsters. Life Sei 22:1407-1412, 1978
23. Wise RA: Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 29:203-210, 1973
24. Gardell LR, Whalen CA, Chattophadyay S, Cavallaro CA, Hubbell CL, Reid LD: The combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcohol Clin Exp Res 21:1435-1439, 1997
25. Holman BL, Carvalho PA, Mendelson J, Teoh SK, Nardin R, Hallgring E, Hebben N, Johnson KA: Brain perfusion is abnormal in
26. cocaine-dependent polydrug users: A study using technetium-99m-HM-PAO and ASPECT. J Nuc! Med 32:1206-1210,1991
27. Brogden RN, Sorkin EM: Isradipine: An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension. Drug Eval 49:618-649,1995
28. Lip GYH, Beevers DG: Alcohol, hypertension, coronary disease and stroke. Clin Exp Pharmacol Physiol 22:189-194, 1995
29. Vailllant GE: The Natural History of Alcoholism Revisited. Cambridge, Harvard University Press, 1995